| 12852 | N | 019047 | 001 | MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLASMA-LYTE 56 IN PLASTIC CONTAINER | BAXTER HLTHCARE | 32MG/100ML;128MG/100ML;234MG/100ML | | [] | 1984-06-15 | Jun 15, 1984 | No | No | No | DISCN | BAXTER HEALTHCARE CORP | 423cb3adc307b68face8dc38a421ebd572f4e269fa18a202c4de0dcc46483239 |
| 12853 | N | 017378 | 002 | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLASMA-LYTE A IN PLASTIC CONTAINER | BAXTER HLTHCARE | 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML | | [] | 1982-11-22 | Nov 22, 1982 | No | Yes | Yes | RX | BAXTER HEALTHCARE CORP | 2d978ce4b03f4ca8091ab88364a403a0ceb51f8678c1809f28e3fff267e4a5dd |
| 12854 | N | 017390 | 001 | CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER | BAXTER HLTHCARE | 37MG/100ML;5GM/100ML;30MG/100ML;119MG/100ML;161MG/100ML;94MG/100ML;138MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | BAXTER HEALTHCARE CORP | 6decf2f71b4d710afc4bb01f848c5b0525dcbf05f54dacb8a25d346d9f5b3e70 |
| 12855 | N | 017438 | 001 | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLASMA-LYTE R IN PLASTIC CONTAINER | BAXTER HLTHCARE | 36.8MG/100ML;30.5MG/100ML;74.6MG/100ML;640MG/100ML;496MG/100ML;89.6MG/100ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BAXTER HEALTHCARE CORP | 99f4177a003f28a5e2124de6844dfc9db12b0d3e9bf8d6470266c70eaee30fce |
| 12856 | N | 018057 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLATINOL | HQ SPCLT PHARMA | 10MG/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | HQ SPECIALTY PHARMA CORP | 04eaa2a6b26d5a64476d208ca18adb1789b74857ed5458cc616f309db07d1500 |
| 12857 | N | 018057 | 002 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLATINOL | HQ SPCLT PHARMA | 50MG/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | HQ SPECIALTY PHARMA CORP | 5bbe94a4e07f82e2459c456196a3d981c2b9e03de971c02124b839d174fdf147 |
| 12858 | N | 018057 | 003 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLATINOL-AQ | HQ SPCLT PHARMA | 0.5MG/ML | | [] | 1984-07-18 | Jul 18, 1984 | No | Yes | No | DISCN | HQ SPECIALTY PHARMA CORP | 2e5a92d42a664af061ddf55f00dd3b65ea30bdc2b1b02c2213b71ab00621af4c |
| 12859 | A | 088653 | 001 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLOCAINE | DENTSPLY PHARM | 3% | | [] | 1984-08-21 | Aug 21, 1984 | No | No | No | DISCN | DENTSPLY PHARMACEUTICAL | ac9a6c70fe8ca95000d3291ac3054b5764d08b9156f2cbc33de26bf5295b97c1 |
| 12860 | A | 089407 | 001 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLOCAINE | FRESENIUS KABI USA | 1% | AP | ["AP"] | 1986-12-01 | Dec 1, 1986 | No | No | No | RX | FRESENIUS KABI USA LLC | 58d9889df6070c34a6e143ae65cb4b0562e941ccc09c8cce3adea88a770cf0db |
| 12861 | A | 089410 | 001 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLOCAINE | FRESENIUS KABI USA | 2% | AP | ["AP"] | 1986-12-01 | Dec 1, 1986 | No | No | No | RX | FRESENIUS KABI USA LLC | 6a96184a6e54d251d24934bc937bcf3f0c39ff15685ff0feb63cb2b26cf20334 |
| 12862 | A | 089517 | 001 | LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLOCAINE W/ LEVONORDEFRIN | DENTSPLY PHARM | 0.05MG/ML;2% | | [] | 1988-04-14 | Apr 14, 1988 | No | No | No | DISCN | DENTSPLY PHARMACEUTICAL | e704304cbe7c4f1804184b8a582ad54c587a3d7b1ff520696dc23bed510f4944 |
| 12863 | A | 089406 | 001 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLOCAINE-MPF | FRESENIUS KABI USA | 1% | AP | ["AP"] | 1986-12-01 | Dec 1, 1986 | No | No | No | RX | FRESENIUS KABI USA LLC | f6d949eb9c0249509d922273727e60a9dd7063394e2c6af43226c57c0447e2e4 |
| 12864 | A | 089408 | 001 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLOCAINE-MPF | FRESENIUS KABI USA | 1.5% | AP | ["AP"] | 1986-12-01 | Dec 1, 1986 | No | No | No | RX | FRESENIUS KABI USA LLC | 96461b7860930e090fdef191e9915544b350bef7cbc709bd3ca854569b279fe7 |
| 12865 | A | 089409 | 001 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLOCAINE-MPF | FRESENIUS KABI USA | 2% | AP | ["AP"] | 1986-12-01 | Dec 1, 1986 | No | No | No | RX | FRESENIUS KABI USA LLC | 9bc4a52d80b111b4b84a9715415f0cec922315372e2e21b5d63b6c6f6f6b83bd |
| 12866 | N | 050309 | 004 | AMPICILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYCILLIN-N | BRISTOL | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 072811592857d241ec0f6c845352d3ce8b182d85f2fc15b6d92aece8f1a9554a |
| 12867 | N | 050309 | 005 | AMPICILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYCILLIN-N | BRISTOL | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 960c5c419e819cd4c42785f1042f06f7b37f6bb4a20f55a70ff1b9904b515c4c |
| 12868 | N | 050309 | 001 | AMPICILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYCILLIN-N | BRISTOL | EQ 125MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | dc404cf659c2c977cf56e680797a5d4c9e49ae12525b20a04aa0a73706cb667b |
| 12869 | N | 050309 | 002 | AMPICILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYCILLIN-N | BRISTOL | EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 4dbafd12eeb1c1b6e344566e094a6a8ccd5c764147adb98801486c3dfbbc52ca |
| 12870 | N | 050309 | 003 | AMPICILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYCILLIN-N | BRISTOL | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 5f61d6b5a06868c241d866129c8585d9cdcb977516b34b6f66a975f4ffa094af |
| 12871 | A | 206589 | 001 | POLYMYXIN B SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYMYXIN B SULFATE | AUROBINDO PHARMA LTD | EQ 500,000 UNITS BASE/VIAL | AP | ["AP"] | 2016-04-04 | Apr 4, 2016 | No | No | No | RX | AUROBINDO PHARMA LTD | 038dd6eb8d77084eb9a6eed03e8cef0f60bf94ee7e6ccaa52eac4fd4f1a2fd11 |
| 12872 | A | 065372 | 001 | POLYMYXIN B SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYMYXIN B SULFATE | FRESENIUS KABI USA | EQ 500,000 UNITS BASE/VIAL | AP | ["AP"] | 2008-01-10 | Jan 10, 2008 | No | No | No | RX | FRESENIUS KABI USA LLC | c44ce015122238db54016bb15173fcb1b1204c013e24f850e26e25d28be5350f |
| 12873 | A | 207322 | 001 | POLYMYXIN B SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYMYXIN B SULFATE | GLAND PHARMA LTD | EQ 500,000 UNITS BASE/VIAL | AP | ["AP"] | 2016-04-14 | Apr 14, 2016 | No | No | Yes | RX | GLAND PHARMA LTD | f8591c529e1f28aba9530e7718943cd2d3d13a540d8ca48a82ae63dd670d21eb |
| 12874 | A | 090110 | 001 | POLYMYXIN B SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYMYXIN B SULFATE | MYLAN ASI | EQ 500,000 UNITS BASE/VIAL | | [] | 2011-06-29 | Jun 29, 2011 | No | No | No | DISCN | MYLAN ASI LLC | c50ba2836498eb13d1a3fb0db76394709fd041e68a075842c19e7ab4fbc5f321 |
| 12875 | A | 060716 | 001 | POLYMYXIN B SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYMYXIN B SULFATE | WEST-WARD PHARMS INT | EQ 500,000 UNITS BASE/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 9ab8060747e34064a6a7220cda037eebec86f09d12d4853cd7b091cc0a169734 |
| 12876 | A | 202766 | 001 | POLYMYXIN B SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYMYXIN B SULFATE | XELLIA PHARMS APS | EQ 500,000 UNITS BASE/VIAL | AP | ["AP"] | 2014-01-15 | Jan 15, 2014 | No | No | No | RX | XELLIA PHARMACEUTICALS APS | 6028491468acb6029f2cdea04aa97bb2c2229f0ebe33e575bc2677b3763bfa67 |
| 12877 | A | 063000 | 001 | POLYMYXIN B SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POLYMYXIN B SULFATE | XGEN PHARMS | EQ 500,000 UNITS BASE/VIAL | AP | ["AP"] | 1994-09-30 | Sep 30, 1994 | No | No | No | RX | XGEN PHARMACEUTICALS DJB INC | c2fe7327bb62e021fada610d8899aeb6811b2cc43bc40fd4a2ff82f5a73c4c1c |
| 12878 | A | 206203 | 001 | POTASSIUM ACETATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM ACETATE | EXELA PHARMA | 2MEQ/ML | AP | ["AP"] | 2015-12-29 | Dec 29, 2015 | No | No | No | RX | EXELA PHARMA SCIENCES LLC | 66060f4821a01cd230104bc0997673db0c5b275b9ed54a2f76897d7cf5b93ed4 |
| 12879 | N | 018896 | 001 | POTASSIUM ACETATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM ACETATE | HOSPIRA | 2MEQ/ML | AP | ["AP"] | 1984-07-20 | Jul 20, 1984 | No | Yes | Yes | RX | HOSPIRA INC | d5587e22375d74cc519af11d99308feb2c915014c508dd83904ab5d45d35b2de |
| 12880 | A | 080204 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | ABRAXIS PHARM | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | 756e4789a2b0671abd6039c960dfc89762662818ba6e44edca86801b907eb5d8 |
| 12881 | A | 084290 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | ABRAXIS PHARM | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | 860b459ce2c2b873b4fb84cbedfbd286ff6c5e255882d1cf8805764f717893b2 |
| 12882 | A | 086713 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | ABRAXIS PHARM | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | 54abc544236a11080875636d99197206cf72242d133d83c36995580b59066aec |
| 12883 | A | 086714 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | ABRAXIS PHARM | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | e136d12bdfe46d3bb6eec3e7d6768a860e41ae7dec027d1c03f75c45a124293d |
| 12884 | A | 087787 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | ABRAXIS PHARM | 2MEQ/ML | | [] | 1982-04-20 | Apr 20, 1982 | No | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | 2d6964bb0f586016c7dfe8bf487f9cd06b2d0ef79730336f7e4cb80fcce84ad7 |
| 12885 | A | 087885 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | ABRAXIS PHARM | 2MEQ/ML | | [] | 1983-02-03 | Feb 3, 1983 | No | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | 1a118352fb346554006854eb8ffdd444b05f193a59d179199964fa1a3c01482c |
| 12886 | A | 088286 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | AKORN | 2MEQ/ML | | [] | 1985-09-05 | Sep 5, 1985 | No | No | No | DISCN | AKORN OPERATING CO LLC | c55b56c7af771967a315e762bc43c03101f893b575c7489ff1980ed5499873a3 |
| 12887 | A | 085870 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | B BRAUN | 2MEQ/ML | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | No | No | RX | B BRAUN MEDICAL INC | 5d8be109519b7b87b8bc747fdbd72772c1a44bb78b4cbf048015426c4d2b0d51 |
| 12888 | A | 080203 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | BAXTER HLTHCARE | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE | a4d1b285783b060cb993bef9097e46bcc6b69349d35c9e76996698285376128f |
| 12889 | A | 085499 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | BAXTER HLTHCARE | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BAXTER HEALTHCARE CORP | 51b9a857860680ee1394200828d6a9380648df255e82251956158a8b000c9edf |
| 12890 | A | 080225 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | FRESENIUS KABI USA | 2MEQ/ML | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | No | No | RX | FRESENIUS KABI USA LLC | 2452d412009bdea807dd2f6588b0024f23fb44a9f7d0668eb201c4ed323e9b1b |
| 12891 | A | 087817 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | FRESENIUS KABI USA | 2MEQ/ML | | [] | 1982-10-20 | Oct 20, 1982 | No | No | No | DISCN | FRESENIUS KABI USA LLC | ca41c1d5e8c33b35716b69175eaffcfde50eebfadb86be5aee2bf0c4c92b8551 |
| 12892 | A | 080225 | 003 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | FRESENIUS KABI USA | 3MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | Yes | RX | FRESENIUS KABI USA LLC | 34a85ec2599084d4603b080c9e795cd8bfefcc01179a4a0880ec8722feed7a98 |
| 12893 | A | 086219 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | GD SEARLE LLC | 1MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GD SEARLE LLC | 33d4ae2f4049fbcb412fdcc1aa5fcc44e2bb5387f9ea592ae2ff02ee5011c4c5 |
| 12894 | A | 086219 | 002 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | GD SEARLE LLC | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GD SEARLE LLC | f272e0ecd8ee13fac4e14a0758d1ad986db17f9b15a214a7cf85f7448b838980 |
| 12895 | A | 086220 | 002 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | GD SEARLE LLC | 2MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GD SEARLE LLC | 384a420cb42e8abb5fb7270d3ee6abc63e275353634174c19f6c362fa598f789 |
| 12896 | A | 086219 | 003 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | GD SEARLE LLC | 3MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GD SEARLE LLC | 1f608053c7217c7d55c2940e38430b509ec64c174c45a617701d3eaf40cab85a |
| 12897 | A | 086220 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | GD SEARLE LLC | 3MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GD SEARLE LLC | 647d5b6888093f45d580e1ed1c6706d060de9142605b636afd925cf868e9f43a |
| 12898 | A | 086219 | 004 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | GD SEARLE LLC | 4MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GD SEARLE LLC | 57cbc1dff46ead271c76eabd449444491b4c553d890be08041c0b2b82f303f46 |
| 12899 | A | 080205 | 003 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | HOSPIRA | 1MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOSPIRA INC | 8ee566c80d4b25212939edbf45e3c305acb04323060031369af7156c84c53ae0 |
| 12900 | A | 083345 | 003 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | HOSPIRA | 1MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOSPIRA INC | 89c3276c8671c0d13d6959b5144b0bc571f0eed30971ede68839734d0438a430 |
| 12901 | A | 083345 | 001 | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | POTASSIUM CHLORIDE | HOSPIRA | 1.5MEQ/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOSPIRA INC | 574540011358bad3d2a96dde6006bab7b1c1da3758a604be97c2bb678055c606 |